| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/04/2008 | US20080214562 Chemical Compounds |
| 09/04/2008 | US20080214561 Amorphous, methylparaben cocrystal and other distinct crystalline forms; distinguished by infrared spectra, X ray powder diffraction patterns and glass transition temperatures neurodegenerative disfunction, pain, cognitive disorders |
| 09/04/2008 | US20080214560 (4-{[5-Fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimidin-2-yl]amino}phenyl)(phenyl)methanone hydrochloride; glycogen synthase kinase-3 inhibitors |
| 09/04/2008 | US20080214559 Compounds with a combination of cannabinoid cb1 antagonism and serotonin reuptake inhibition |
| 09/04/2008 | US20080214558 2-[(2-(4-methylpyrazin-1-yl)-3-fluoro-5-pyridinyl)amino]-4-[(3-chloro-4-fluoro) or (3-cyanomethyl)phenylamino]pyrimidine; 2-[(4-(4-methylpyrazin-1-yl)-phenyl)amino]-4-[(3-chloro-4-fluoro) or (3-cyanomethyl)phenylamino]pyrimidine; colon, breast, stomach, urogenital, pancreatic cancers, leukemia lymphoma |
| 09/04/2008 | US20080214557 Method for preparation of pharmaceutical composition having improved disintegratability and pharmaceutical composition manufactured by same method |
| 09/04/2008 | US20080214556 Stabilizing with intravenous infusion followed by oral sustained release maintenance formulation; reducing blood plasma HbA1x levels |
| 09/04/2008 | US20080214555 Aqueous intravenous solution containing dextrose and/or sodium chloride; rapid delivery, low viscosity; free of propylene glycol and/or polyethylene glycol |
| 09/04/2008 | US20080214554 Methods for preventing or treating cardiac arrhythmia |
| 09/04/2008 | US20080214553 2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists |
| 09/04/2008 | US20080214551 Treatment of Burns |
| 09/04/2008 | US20080214550 Novel inhibitors of folic acid-dependent enzymes |
| 09/04/2008 | US20080214549 N-Substituted Glycine Derivatives: Hydroxylase Inhibitors |
| 09/04/2008 | US20080214548 2-Cyano-Pyrimidines and-Triazines as Cysteine Protease Inhibitors |
| 09/04/2008 | US20080214547 Using small molecules as binding ligands, for the recruitment of Fas-associated death domain protein, activation of death-inducing signaling complex, caspase-8, and apoptosis in malignant cells; anticarcinogens, antitumor agents; enhanced cellular differentiation, minimizing cytolysis to healthy cells |
| 09/04/2008 | US20080214546 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 09/04/2008 | US20080214545 4-{3-tert-butyl-5-[({[4-(pyridin-4-yloxy)phenyl]amino}carbonyl)amino]-1H-pyrazol-1-yl}-N-(2-pyrrolidin-1-ylethyl)benzamide; antiproliferatives; angiogenesis inhibitors |
| 09/04/2008 | US20080214544 N-(4-(6-(1-methyl-6-oxo-2-(phenylamino)-1,6-dihydropyrimidin-5-yl)pyridin-3-yloxy)pyridin-2-yl)pyrrolidine-1-carboxamide; anticarcinogenics, antiproliferatives, angiogenesis inhibitors; hepatocyte growth factor mediated diseases |
| 09/04/2008 | US20080214543 Antiandrogen; prostate cancer; excellent oral pharmacokinetics |
| 09/04/2008 | US20080214542 1-(5-methoxyisoindolin-2-yl)-6-[4-(3-trifluoromethylphenyl)piperazin-1-yl]hexan-1-one; amidation of an isoindole with a 4-phenylpyrimidinylalkanoic acid or amination of a N-haloalkylcarbonyl isoindole with a 4-phenylpyrimidine; antidepressant, neuroleptic agent; drug abuse, impotency, Parkinson's Disease |
| 09/04/2008 | US20080214541 Such as 2-(1-naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; differentiating cells into osteoblast lineage; osteoporosis |
| 09/04/2008 | US20080214540 3-[(phenyl or benzothiazol-2-yl)methyl]indole-N-acetic acids and esters; analgesics; aldose reductase inhibitors; diabetes complications including cataracts, retinopathy, nephropathy, and neuropathy; side effect reduction |
| 09/04/2008 | US20080214539 Benzisoxazole Piperidine Compounds and Methods of Use Thereof |
| 09/04/2008 | US20080214538 Pyridoindolone Derivatives Substituted in the 3-Position by a Phenyl, Their Preparation and Their Application in Therapeutics |
| 09/04/2008 | US20080214537 Bridged phenanthridines |
| 09/04/2008 | US20080214536 4-((4aR,10bR)-8,9-Dimethoxy-1,2,3,4,4a,10b-hexahydro-phenanthridin-6-yl)-N-(2-methoxyethyl)-N-methyl-benzamide; phosphodiesterase 4 inhibitors; respiratory system disorders |
| 09/04/2008 | US20080214535 Rapidly solvent removed product of 5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one (aprepitant) and carrier; solubility, bioavailability, drug delivery; neurokinin 1 receptor antagonist, antiemetics |
| 09/04/2008 | US20080214534 (1,10B-Dihydro-2-(Aminoalkyl-Phenyl)-5H-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors |
| 09/04/2008 | US20080214533 Anticoagulants, thrombolytic agents; amidating a p-(hydroxy-protected alkylamino)aniline with a (hetero)arylaminocarbonyl-(hetero)aryl carboxylic acid; deblocking, reacting with cyanogen bromide and cyclizing |
| 09/04/2008 | US20080214531 Administering combination of niacin and meloxicam; reducing prostaglandin levels |
| 09/04/2008 | US20080214530 Photo-Activated Disinfection |
| 09/04/2008 | US20080214529 Such as n-{3-[1-(3,3-dimethyl-butyl)-4-hydroxy-2-oxo-1,2,4a,5,6,7-hexahydro-pyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxo-1,4-dihydro-1 lambda-6-benzo[1,2,4]thiadiazin-7-yl}-methane sulfonamide; hepatitis C viral infections; inhibiting replication |
| 09/04/2008 | US20080214528 e.g. N-[3-{1-[(cyclobutyl)amino]-4-hydroxy-2-oxo-1,2-dihydro-quinolin -3-yl}-1,1-dioxo-1,4-dihydro-1 lambda 6-thieno[2,3-e][1,2,4]thiadiazin-7-yl)methyl]methane-sulfonamide; viricides for infections caused by an RNA-containing virus; hepatitis C virus (HCV) polymerase inhibitor; liver cirrhosis |
| 09/04/2008 | US20080214527 Hiv Integrase Inhibitors |
| 09/04/2008 | US20080214526 Macrocyclic Compounds and Compositions Useful as Bace Inhibitors |
| 09/04/2008 | US20080214525 Alkyl 4- [4- (5-Oxo-2,3,5, 11A-Tetrahydo-5H-Pyrrolo [2, 1-C] [1,4] Benzodiazepine-8-Yloxy) -Butyrylamino]-1H-Pyrrole-2-Carboxylate Derivatives and Related Compounds For the Treatment of a Proliferative Disease |
| 09/04/2008 | US20080214524 e.g. N-[2-(3-fluorophenyl)ethyl]-N'-isoquinolin-5-ylurea; opioid receptor inhibitor; analgesic, antiinflammatory agent; inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity |
| 09/04/2008 | US20080214523 Method for treating severe heart failure and medicament therefor |
| 09/04/2008 | US20080214522 Macrocyclic indole compounds, e.g., (7R)-14-cyclohexyl-21,24-dimethyl-7,8-dihydro-6H-7,11-(epiminoethanoiminopropanothio iminomethano)indolo[1,2-e][1,5]benzoxazocin-15-one 17,17-dioxide; hepatitis C virus polymerase inhibitors |
| 09/04/2008 | US20080214521 N-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-Im]pyrrolo[3,4-j]][1,7]benzodiazonin-11-yl]-N-methylbenzamide; staurosporine derivative; FLT-3 kinase inhibitor, activator of permeabilization of mitochondrial outer membrane, as of BAK; anticarcinogenic |
| 09/04/2008 | US20080214520 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder |
| 09/04/2008 | US20080214519 Chromane Substituted Benzimidazole Derivatives as Acid Pump Antagonists |
| 09/04/2008 | US20080214518 Potentiation; overcoming drug resistance of such as klebsiella pneumoniae; kits |
| 09/04/2008 | US20080214517 Modulation of the Expression of Estrogen Receptors for the Prevention or Treatment of Heart Disease |
| 09/04/2008 | US20080214516 Methods and compositions for inhibiting tumor growth |
| 09/04/2008 | US20080214515 Farnesoid X receptors agonist; liver diseases, hepatitis; increase HDL cholesterol, lower triglycerides |
| 09/04/2008 | US20080214514 Derivatives in which cholesterol or a cholesterol moiety is attached via ester, amide, or ether bonds to one of a variety of "linkers," e.g., chemical groups including alkyl chains and aromatic groups, which are then connected to fullerene moiety; steroid moiety confers solubility in biofluids; imaging |
| 09/04/2008 | US20080214513 Method of treating middle ear infections |
| 09/04/2008 | US20080214512 Pharmaceutical preparation containing a gestagen, and kit and method for treating endometriosis using the preparation |
| 09/04/2008 | US20080214511 e.g. 5-Amino-4'-chloro-13-dihydrospiro[indene-2,5'-pyrrolo[2,3-d]pyrimidin]-6'(7'H)-one; Calcitonin Gene-Related Peptide Receptor antagonist; anlgesic agent; headache, migraine or cluster headache |
| 09/04/2008 | US20080214510 Treating patient having meibomian gland disease, aqueous tear deficiency, delayed tear clearance or recurrent comeal epithelial erosion by topically administering an effective amount of tetracycline or derivative to eye |
| 09/04/2008 | US20080214509 Methods for enhancing the efficacy of vascular disrupting agents |
| 09/04/2008 | US20080214508 O-phosphonooxymethyl propofol disodium salt; anasthetic, analgesic, anxiolytic agent, antidepressant; bioavailable and pharmacologically active when given by intravenous, than subcutaneous or rectal administration |
| 09/04/2008 | US20080214507 Mono-and-di-phosphates of 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile |
| 09/04/2008 | US20080214506 Applying to patient a medicament for transdermal, oral, or ophthalmological administration comprising ethanol, vitamin B6 or analog thereof, and an ion channel affinity component; providing transport vehicle of meperidine, lecithin, or DMSO for transfer of vitamin B6 or analog through cell membrane |
| 09/04/2008 | US20080214505 Risedronate compositions and their methods of use |
| 09/04/2008 | US20080214504 Vitamin B6 Related Compounds and Methods for Recovery From Trauma |
| 09/04/2008 | US20080214503 Diethyl[2-({[7-[(4-fluorophenyl)methyl]-4-hydroxy-3-({[2-(methyloxy)ethyl]amino}carbonyl)-2-oxo-1,5-naphthyridin-1(2H)-yl]acetyl}amino)ethyl]phosphonate; alone or with a second enzyme inhibitor |
| 09/04/2008 | US20080214501 Bruton's tyrosine kinase (Btk) activity probe comprising a Btk inhibitor moiety, a reporter moiety, and a linker moiety that links the inhibitor moiety to the reporter moiety; probes are used to characterize and develop Btk-selective inhibitors intended for therapeutic use |
| 09/04/2008 | US20080214500 Injectable cement composition for orthopaedic and dental use |
| 09/04/2008 | US20080214499 Lowering lipids in a living body by use of a cyclic tetrasaccharide represented by formula of cyclo{>6)- alpha -D-glucopyranosyl-(1>3)- alpha -D-glucopyranosyl-(1>6)- alpha -D-glucopyranosyl-(1>3)- alpha -D-glucopyranosyl-(1>}, and/or glycosylated compound(s) thereof |
| 09/04/2008 | US20080214498 Osmotic glucose polymer, electrolyte, and buffer solutions administered to patient after heat sterilization; not subjected to glucose-like degradation during storage and sterilization, and having a pH value in neutral range |
| 09/04/2008 | US20080214497 Water dispersible policosanol cyclodextrin complex and method of its production |
| 09/04/2008 | US20080214496 Iron(III) polymaltose complex and iron(III)maltodextrin complex; improvements in immune defence and/or brain performance in patients who had a normal hematological result in respect of iron status |
| 09/04/2008 | US20080214495 Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa |
| 09/04/2008 | US20080214494 Method of drug delivery by carbon nanotube-chitosan nanocomplexes |
| 09/04/2008 | US20080214493 Use of Flavone Compounds as Potassium Channel Inhibitors |
| 09/04/2008 | US20080214492 Treating inflammation, oxidative stress, glycation/dysinsulinemia, platelet function, homocysteine levels and acetylcholinesterase inhibition; Alzheimer's disease; Parkinson's disease; cardiovascular diseases arterosclerosis and risk factors thereof including elevated cholesterol and blood pressure |
| 09/04/2008 | US20080214491 Methods of Inhibiting the Interaction Between S100 and the Receptor for Advanced Glycation End-Products |
| 09/04/2008 | US20080214490 Administering purinergic receptor agonist P1, P4-di(uridine 5'-) tetraphosphate for secretion stimulation; vaginal dryness associated with menopause, chemotherapy, and various disease states as well as the treatment of vulvar pain |
| 09/04/2008 | US20080214489 Aptamer-mediated intracellular delivery of oligonucleotides |
| 09/04/2008 | US20080214488 TRIGGERED RNAi |
| 09/04/2008 | US20080214487 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/04/2008 | US20080214485 Targeting inhibitory nucleic acid molecules to specific regions of an RNA encoding a polypeptide of interest can lead to the induction of a T cell response in an individual against the polypeptide; target polypeptide may be a tumor antigen or viral antigen |
| 09/04/2008 | US20080214484 Nucleic acids encoding sarcocystis neurona antigen and uses thereof |
| 09/04/2008 | US20080214483 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta) |
| 09/04/2008 | US20080214482 Retromer-based assays and methods for treating alzheimer's disease |
| 09/04/2008 | US20080214481 Methods of Treatment of Endobronchial Infections |
| 09/04/2008 | US20080214480 Method for Treating Sickle Cell Disease and Sickle Cell Disease Sequalae |
| 09/04/2008 | US20080214479 Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose |
| 09/04/2008 | US20080214471 Method for inhibition of viral infection |
| 09/04/2008 | US20080214458 Administering a modulator that interacts with a neurotransmitter receptor; synapse-specific proteins, Rab3A, NMDA-1, synapsin-1, tetanus toxin receptor, BDNF-receptor and a GABA receptor |
| 09/04/2008 | US20080214455 5Z)-2-[(2,6-Dichlorophenyl)amino]-5-{[3-(4-morpholinyl)-6-quinoxalinyl]methylidene}-1,3-thiazol-4(5H)-one; inhibiting hYAK3 proteins; autoimmunity, HIV, cancer, drug-induced anemias, myelodysplastic syndrome, aplastic anemia myelosuppression, cytopenia |
| 09/04/2008 | US20080214453 Administering soluble receptor for advanced glycation endproduct (sRAGE) |
| 09/04/2008 | US20080214452 Method for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocation |
| 09/04/2008 | US20080214449 Administering N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide |
| 09/04/2008 | US20080214445 Contains N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine |
| 09/04/2008 | US20080214443 Compositions and Methods for Control of Insect Infestations in Plants |
| 09/04/2008 | US20080214437 RNA interference; gene therapy; inhalers |
| 09/04/2008 | US20080214436 Methods and compositions for the treatment of cancer or other diseases |
| 09/04/2008 | US20080214394 N-(4-Pyridyl)Methylsulfonamides For Combating Arthropodal Pests |
| 09/04/2008 | US20080213889 Increasing oocyte maturation via treating oocyte in vitro with gonadotropin hormone and hydrolase inhibitor; treating fertility disorders |
| 09/04/2008 | US20080213888 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 09/04/2008 | US20080213863 Method of Controlling Viral Outbreak |
| 09/04/2008 | US20080213861 Using targeted gene expression inhibition to treat and prevent viral infection |
| 09/04/2008 | US20080213822 Methods for diagnosing celiac sprue and reagents useful therein |
| 09/04/2008 | US20080213793 Antibodies that bind receptor protein designated 2f1 |
| 09/04/2008 | US20080213786 Using lectin modulators as treatments for cell proliferative and inflammatory disorders |
| 09/04/2008 | US20080213427 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 09/04/2008 | US20080213409 Triple anti-irritant composition |